[A Case of Recurrent Gastric GIST with Long-Term Survival after Multidisciplinary Treatment].

Q4 Medicine Japanese Journal of Cancer and Chemotherapy Pub Date : 2024-05-01
Ryosuke Machi, Kaname Ishii, Kentaro Hayashi, Hironori Minami, Yuki Yamasaki, Yukari Yamaguchi, Katsunobu Oyama, Masao Yagi
{"title":"[A Case of Recurrent Gastric GIST with Long-Term Survival after Multidisciplinary Treatment].","authors":"Ryosuke Machi, Kaname Ishii, Kentaro Hayashi, Hironori Minami, Yuki Yamasaki, Yukari Yamaguchi, Katsunobu Oyama, Masao Yagi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>An 80-year-old male patient presented with a 2.5 cm-sized submucosal tumor on the greater curvature side of the upper gastric body during an endoscopic examination in 200X. We diagnosed gastric GIST by biopsy and performed laparoscopic- assisted partial gastrectomy. Imatinib was started as postoperative adjuvant therapy, but was discontinued after 1 month due to eyelid edema. The patient was followed up with a contrast-enhanced CT scan and a PET-CT scan. A 7 cm-sized mass in the gastrosplenic region was discovered on a 200X+7 years CT scan; this mass was thought to be possible recurrence of peritoneal dissemination. The patient did not want to undergo surgery or drug treatment, and was followed up. Five months later he complained of abdominal pain. The CT scan showed that the mass had shrunk slightly, but a small amount of ascites was observed, and tumor rupture was suspected. Therefore, we performed resection of the tumor in the office. Numerous disseminated nodules were found in the intra-abdominal cavity. Pathological examination revealed recurrence of GIST, and the patient was started on imatinib 200 mg/day. The dose was temporarily increased to 300 mg/day, but was reduced again to 200 mg/day 1 month later due to eyelid edema. Thereafter, the dose was temporarily discontinued due to stomatitis, and from 200X+8 years, 200 mg/day was administered for 2 weeks and then discontinued for 2 weeks. At present, 14 years after the first surgery and 6 years after recurrence, he remains alive thanks to imatinib continuation.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

An 80-year-old male patient presented with a 2.5 cm-sized submucosal tumor on the greater curvature side of the upper gastric body during an endoscopic examination in 200X. We diagnosed gastric GIST by biopsy and performed laparoscopic- assisted partial gastrectomy. Imatinib was started as postoperative adjuvant therapy, but was discontinued after 1 month due to eyelid edema. The patient was followed up with a contrast-enhanced CT scan and a PET-CT scan. A 7 cm-sized mass in the gastrosplenic region was discovered on a 200X+7 years CT scan; this mass was thought to be possible recurrence of peritoneal dissemination. The patient did not want to undergo surgery or drug treatment, and was followed up. Five months later he complained of abdominal pain. The CT scan showed that the mass had shrunk slightly, but a small amount of ascites was observed, and tumor rupture was suspected. Therefore, we performed resection of the tumor in the office. Numerous disseminated nodules were found in the intra-abdominal cavity. Pathological examination revealed recurrence of GIST, and the patient was started on imatinib 200 mg/day. The dose was temporarily increased to 300 mg/day, but was reduced again to 200 mg/day 1 month later due to eyelid edema. Thereafter, the dose was temporarily discontinued due to stomatitis, and from 200X+8 years, 200 mg/day was administered for 2 weeks and then discontinued for 2 weeks. At present, 14 years after the first surgery and 6 years after recurrence, he remains alive thanks to imatinib continuation.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[多学科治疗后长期存活的复发性胃腺瘤病例]。
一位80岁的男性患者在200X年的一次内镜检查中发现上胃体大弯侧有一个2.5厘米大小的黏膜下肿瘤。我们通过活检确诊为胃 GIST,并在腹腔镜辅助下进行了胃部分切除术。术后开始使用伊马替尼进行辅助治疗,但一个月后因眼睑水肿而停药。患者接受了对比增强CT扫描和PET-CT扫描随访。200X+7 年 CT 扫描发现胃脾区域有一个 7 厘米大小的肿块;该肿块被认为可能是腹膜播散的复发。患者不愿接受手术或药物治疗,并接受了随访。五个月后,他主诉腹痛。CT 扫描显示肿块略有缩小,但观察到少量腹水,怀疑肿瘤破裂。因此,我们在诊室对肿瘤进行了切除。腹腔内发现大量播散性结节。病理检查显示 GIST 复发,患者开始服用伊马替尼 200 毫克/天。剂量暂时增加到每天 300 毫克,但 1 个月后由于眼睑水肿,剂量再次减少到每天 200 毫克。此后,由于口腔炎而暂时停药,从 200X+8 年开始,每天服用 200 毫克,持续 2 周,然后停药 2 周。目前,在第一次手术后的 14 年和复发后的 6 年,由于继续服用伊马替尼,他仍然活着。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
期刊最新文献
[Ⅰ. Current Topics in Pleural Mesothelioma]. [Ⅱ. Updates on Therapeutic Strategies for Malignant Mediastinal Tumors]. [Ⅲ. Latest Topics of Lung Neuroendocrine Neoplasms]. [A Case of Appendiceal Mucinous Carcinoma with Bladder Invasion Developed from Abscess-Forming Appendicitis, Which Was Curatively Resected after Chemotherapy]. [A Case of Intestinal Lymphoma with Two Perforation in a Short Period Time].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1